Francoise de Craecker's most recent trade in X4 Pharmaceuticals Inc was a trade of 1,500 Common Stock done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals Inc | Francoise de Craecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 1,500 | 4,722 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Francoise de Craecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 45,000 | 96,667 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Francoise de Craecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 6,667 | 6,667 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Francoise de Craecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2021 | 12,250 | 12,250 | - | - | Stock Option (right to buy) |